Autologous Vaccination of Stage 4 Renal Cell Carcinoma Combined With Sunitinib
NCT00890110
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
13
Enrollment
OTHER
Sponsor class
Conditions
Renal Cell Cancer
Interventions
BIOLOGICAL:
Autologous renal cell vaccine based on DNP modified cells
Sponsor
Hadassah Medical Organization